Enamine selects Chemspace to advance its catalog business

KYIV, UKRAINE, June 24, 2021 /EINPresswire.com/ — Enamine Ltd. a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments, and screening compounds announced today that it forms a strategic alliance with Chemspace, an online marketplace leader for small molecules, and will use the company as its exclusive aggregator platform to supply worldwide all its catalogue products starting from January 1, 2022. Chemspace will be the only online commercial resource in the world that will enable accessing and searching all Enamine’s catalogs. Enamine will continue direct supplies to the drug discovery community and at the same time will cease its historical collaborations with all other compound aggregator platforms.

Enamine holds colossal chemical resources: more than 240,000 building blocks and over 2.7 million screening compounds already accumulated in stock. Such chemicals account for more than half of the world’s commercially accessible stock of small molecules. The company has been able to leverage its knowledge and create catalogs of over 20 billion highly feasible make-on-demand compounds (MADE® Building Blocks and REAL® compounds). These catalogs are exclusively made for searches at Chemspace so that every researcher can explore options available for structure modifications in their research projects.

“We are happy to partner with Chemspace as their unique technology can manage the sizes of our huge catalog evolutions and also provide punch-out integration options with modern procurement systems. This alliance will allow us to concentrate more on our flourishing CRO business”, said Dr. Vladimir Ivanov, CSMO at Enamine. He continued: “At any time Enamine can continue to quickly give a supportive hand to provide to the customers its scientific expertise in compounds resupplies, synthesis of analogues, and compound libraries. The Chemspace team will ultimately assure the same efficient and transparent communication level with our clients. We are highly confident Chemspace will seamlessly support our collaboration with them.” Yurii Moroz, CEO of Chemspace commented: “This alliance is a significant milestone for Chemspace, driving our business forward to anker further our world leading position as a platform with the largest catalog of early discovery chemical products”. He added: “Our mutual commitment to the success of this alliance shall see quickly full satisfaction of end users.”

Contacts

Enamine Ltd.
Vladimir Ivanov v.ivanov@enamine.net

Chemspace LLC
Yurii Moroz yurii.moroz@chem-space.com

About Enamine https://enamine.net/

Enamine is a global leading designer and largest producer of building blocks (240,000+) and screening libraries (2.7M+ compounds). REAL® Database https://enamine.net/compound-collections/real-compounds/real-database is a collection of 1.95 billion enumerated compounds that can be synthesized within just 3 weeks with over 80% success rate. REAL® Space https://enamine.net/compound-collections/real-compounds/real-space-navigator is a database of synthons and reactions that have been prepared to enable searches in around 20 billion possible combinations using InfiniSEE by BioSolveIT. MADE® Building Blocks https://enamine.net/building-blocks/make-on-demand-building-blocks are a catalogued collection of 210 million highly feasible building blocks. Enamine provides expertise in advanced organic synthesis, library synthesis, and medicinal chemistry. In 2011 Enamine established a pre-clinical service unit including ADME, in-vivo PK studies and High Throughput Screening under the brand name “Bienta”, allowing the company to tackle since that time fully integrated or à-la-carte research programs.

About Chemspace https://chem-space.com/

Chemspace was launched in 2016 to create a specialized comprehensive catalog of screening compounds and building blocks. It is powered with the latest IT technologies in chemical structure data storage and searches. Today Chemspace is the largest online catalog of small molecules. Users can perform a convenient and fast search in 20 billion building blocks, fragments, and screening compounds provided by the most trustful suppliers of in-stock and unique make-on-demand molecules. Chemspace also provides sourcing and procurement services.

Michael Bossert
Enamine Ltd
m.bossert@enamine.net


Source: EIN Presswire

Fluoramics introduces Lox-8 NF Oil, a Non-Fluorescing Oil for Black Light Inspection

Fluoramics' LOX-8 NF Oil Kit contains oil plus four microfiber swabs.

Fluoramics’ LOX-8 NF Oil Kit contains oil plus four microfiber swabs.

Fluoramics has developed a non-fluorescing product to lubricate critically clean surfaces that require black light inspections.

Our goal is to help customers solve problems and I’m pleased to say we successfully developed LOX-8 NF Oil as a solution to black light inspection issues.”

— Gregg Reick, President and Chief Chemical Engineer

WINONA, MN, UNITED STATES, June 24, 2021 /EINPresswire.com/ — Fluoramics, Inc. has released a new product, LOX-8 NF Oil, which will not fluoresce during black light inspections.

LOX-8 NF Oil is a low-viscosity inert PCTFE lubricant. It is engineered from oxygen-approved chemistries and allows for lubrication of critically clean surfaces that require black light inspection. Use LOX-8 NF Oil on o-rings, seals and rubber gaskets, and to prevent galling in mating surfaces. Non-fluorescing oil is also used in the maintenance of gas supplies and filters for laser systems.

LOX-8 NF Oil Kits (part 9722160) contain 5 mL of oil plus four microfiber swabs (3.93" x .307") suitable for clean room use. The kit are packaged with both oil and swabs in order to facilitate thin-film applications. Fluoramics also offers sets of 25 microfiber swabs in two sizes: 4.92" x .56" (part 9790055) and 3.93"x.307" (part 9790050).

LOX-8 NF Oil is easy to apply: simply put a drop or two of LOX-8NF Oil on a microfiber swab and apply to desired area.

Fluoramics, Inc. is a leading manufacturer of sealants, greases, lubricants and rust inhibitors, all of which are engineered PTFE solutions. Founded in 1967, the company is based in Winona, Minnesota, and proudly manufactures all of its products in the United States. To learn more about Fluoramics’ products, please visit the company's website at www.fluoramics.com.

Patti Reick
Fluoramics, Inc
+1 507-205-9216
email us here
Visit us on social media:
Facebook
LinkedIn


Source: EIN Presswire

TechnologyCatalogue.com releases three-year report on the platform

TechnologyCatalogue.com releases three-year report on the platform

company logo

TechnologyCatalogue.com is the fastest-growing technology platform that aims to connect Energy companies with innovative technology.

Discover most common themes, most popular keyword, most searched technologies and other key trends in the last three years on the platform.

End-user activities on the platform mirror energy sector trends

Activities of end-users on the platform mirror the trends in the energy sector as a whole.”

— Report

DELFT, ZUID-HOLLAND, NETHERLANDS, June 24, 2021 /EINPresswire.com/ — ● As of end-May 2021, TechnologyCatalogue.com received close to 800 technology registrations from over 400 suppliers from all over the globe
● The platform has since been viewed more than 470,000 times by users from 180+ plus countries
● Digitalisation, renewable energy, and safety and maintenance are the most popular themes on the platform
● Majority of end-users used the following keywords to search for technologies: inspection drones, gas leak detection, digital twin, corrosion and hydrogen
● Insights blog on women in the energy sector remains the most popular knowledge content on the website

TechnologyCatalogue.com, the fastest-growing technology platform for the energy transition, marked its third year anniversary with unprecedented growth in registrations and platform activities.

In a report published in June, TechnologyCatalogue.com revealed the most common themes, most popular keywords and most searched technologies on the platform in the last three years.

“Activities of end-users on the platform mirror the trends in the energy sector as a whole. For instance, digitalisation and renewable energy being popular themes reflects the increasing indispensability of digitalisation as a business model and the inevitable journey towards clean energy sources, respectively,” the report said.

Aside from a platform that gives end-users a direct access to intelligently curated technologies from around the world, TechnologyCatalogue.com has also exposed a viable, efficient and affordable long-term alternative to physical exhibitions for technology suppliers to take advantage of.

“TechnologyCatalogue.com has grown to be more than just a listing website for technologies in the energy sector but a platform of choice for energy companies finding technological solutions for their business,” the report concluded.

Jeremiah Fajardo
TechnologyCatalogue.com
jeremiahfajardo@technologycatalogue.com

About TechnologyCatalogue.com


Source: EIN Presswire

Jeuvenile Cosmetics Products is now Available at Gratis, Turkey

Jeuvenile Cosmetics

ISTANBUL, TURKEY, June 24, 2021 /EINPresswire.com/ — Jeuvenile announced that they started selling their products at Gratis, biggest cosmetics retailer in Turkey.

Gratis, which is the leader in the personal care sector with the most extensive store network in Turkey, is a personal care and cosmetics store chain established in Istanbul in 2009. Gratis is Turkey's number 1 personal care market, bringing together more than 30,000 products in 13 different categories, from make-up products to baby care, from cleaning and hygiene to snacks.

Gratis, which opened its first store in Istanbul Metrocity AVM on July 17, 2009, serves with more than 700 stores in 80 provinces as of 2021. Gratis has more than 5 thousand employees. All store employees of the brand, which cares about increasing women's employment in Turkey, are women.

“We are happy to announce that Jeuvenile Cosmetics products are now available in Gratis, Turkey” said chairman, Altuğ Aynur of Jeuvenile Cosmetics.

Media Relations
Jeuvenile Cosmetics
+ +90 531 395 15 26
info@jeuvenile.com
Visit us on social media:
LinkedIn


Source: EIN Presswire

GenoFAB and LabTAG partner to increase the productivity of life sciences

test tube labeled with a barcode

Adding a barcode to a laboratory sample label makes it possible to retrieve all the information about the sample that cannot be printed on the label.

genofab software running on a mobile device to print barcode labels

GenoFAB allows users to print barcode labels from mobile devices

The partnership between a LIMS company and a label manufacturer enables any lab to track laboratory samples using barcode technology

Every sample deserves its own barcode.”

— Jean Peccoud

FORT COLLINS, CO, USA, June 23, 2021 /EINPresswire.com/ — Properly labeling laboratory specimens is the most effective way to increase the productivity of research teams. GenoFAB and LabTAG have joined forces to make it easier for any laboratory to use barcode technologies to identify and track their valuable samples.

It is estimated that, in the US alone, $28bn per year are wasted in preclinical research that fails to deliver reproducible results. Sample and reagent identification explains 36.1% of the problems and represents the main source of irreproducibility.

Many laboratories are still relying on handwritten labels to identify their samples because printing labels is surprisingly challenging in a laboratory environment. Many samples in the life sciences are very small and exposed to very harsh conditions. A working labeling solution requires assembling specialized labels that can withstand the most extreme conditions from ultra-low to ultra-high temperatures. It also requires a label printer compatible with the labels and software to control the printer.

GenoFAB provides a web-based software solution allowing users to document their samples and generate barcode labels that make it possible to retrieve the sample documentation. Unlike other label printing solutions that only print labels but lack a data management system, GenoFAB users can attach as much data they need to document their samples. Furthermore, GenoFAB's label design and printing solution are completely web-based. It does not require users to use a specific type of computer and install third-party software on their computer to design and print their labels.

“Every sample deserves its own barcode,” said Jean Peccoud, CEO of GenoFAB. “Printing labels should be the first step of any experiment”.

LabTAG manufactures specialty labels for the life science industry. Their unmatched expertise and reputation in this market made them a natural partner to develop an integrated sample labeling solution that will meet the needs of the most demanding laboratories. GenoFAB users will find in LabTAG, a trusted partner that will help them select the labeling solution that will meet their needs and requirements.

“GenoFAB label printing solution removes a lot of friction that many users find difficult to overcome,” said George Ambartsoumian, CEO of LabTAG. “We are looking forward to providing GenoFAB users with the specialized labels they need in their harsh laboratory environments to identify their specimens, track their samples, and manage their inventory”.

About GenoFAB: GenoFAB’s web-based laboratory information management system (LIMS) allowing research organizations to increase the quantity and quality of data they can produce with their existing resources. It reduces the probability of project failure by extracting actionable information from raw data in real time.

LabTAG, a division of GA International Inc., is a full-scale research and development company that manufactures specialty labels and tapes including cryogenic, xylene, and autoclave resistant, wrap-around (self-laminating) labels, and much more.

Jean Peccoud
GenoFAB, Inc.
+1 (970) 205-9158
peccoud@genofab.com

Using barcodes to track samples


Source: EIN Presswire

ESG Enterprise Releases New ESG Reporting Software Assisting Dubai Companies

ESG-Reporting-Software-ADX-Companies

ESG Reporting Software for ADX Listed Companies

esg-software

ESG Software

esg-enterprise

ESG Enterprise

The ESG software simplifies compliance with environmental, social and governance disclosure guidelines on the Abu Dhabi Exchange

ESG Enterprise reporting tool automatically collects data relevant to reporting, auto-generates report for auditor & guides them step by step. The results are efficient & comply with standards.,”

— Vitaly Izhevski

HOUSTON, TEXAS, USA, June 23, 2021 /EINPresswire.com/ — ESG Enterprise and LR Consultants has brought to the market an innovative environmental, social and governance (ESG) reporting software that helps public listed companies in the UAE comply with the new mandated Abu Dhabi Exchange and Dubai Financial Market ESG disclosure requirements.

This All-in-One digital platform offers ESG and data analytics solutions on a Software-as-a-Service (SaaS) basis. The company’s products are designed to help businesses, investors and governments reduce ESG risks, automate ESG reporting and capture opportunities in the transition to a sustainable-growth and low-carbon economy. Demand is rising for ESG solutions that can reduce the time and resources required for compliance. LR Consultants/ESG Enterprise is meeting this market need.

The Abu Dhabi Exchange and Dubai Financial Market are committed to driving sustainability in financial markets. In alignments with the UAE National Vision 2021 and the Abu Dhabi Economic Vision 2030, Both have developed ESG disclosure guidance to support the listed issuer’s sustainability journey. All companies publicly listed in the UAE must disclose their ESG performance using the ADX/DFM disclosure guidance. On January 10, 2021, SCA set out in more detail what sustainability reports must contain and confirmed that the report should be published annually and stated, “public joint-stock companies listed on the Abu Dhabi Securities Exchange or the Dubai Financial Market (DFM) in the UAE (Listed PJSCs) must publish a sustainability report.”.

“Our ESG reporting tool is specially built for Global Reporting Initiative requirements and comply with all ADX and DFM guidelines. The tool helps the company comply by assessing its ESG performance, automatically collects data relevant to reporting, auto-generates the report for auditor reviews, and guides them step by step. The results are efficient, comply with standards, save time and resources, etc.,” said Vitaly Izhevski, the CTO of ESG Enterprise. “ESG reporting tools drive corporate ESG disclosures across the world with metric-based targets and sustainable business models.”

“We are extremely proud and excited to be in partnership with ESG Enterprise and able to offer this revolutionary software to the local market. We feel the timing is right with the recent announcement from the SCA on mandatory ESG requirements. We view ESG as a dynamic landscape, bringing great challenges and opportunities. This software will help organizations navigate the transition and raise the ESG flag in the UAE. We firmly believe that advanced technology are the keys to long-term ESG success. While operationalizing ESG is critical to delivering on our sustainability commitments” reflects Andrew Jamieson, ESG Director at LR Consultants, “

ESG Enterprise / LR- Consultants offer a single, all-in-one solution to data collection and reporting to ensure compliance with ADX and DFM requirements. This reporting SaaS tools enable leaders and professionals to create and implement ESG strategies efficiently. The ESG advanced reporting tool provides sustainability analysts full disclosure solutions to create seamless data collections, track data and collection progress, generate PDF disclosures, and form action plans in just a few simple steps, saving time and resources.

ESG Enterprise also partners with LR Consultants with all ESG-related advisory services. “The partnership will equip the Middle East North African (MENA) market with the knowledge and practical solutions required to integrate ESG into your company’s operations. At LR Consultants we focus on what is significantly material, we have scientifically trained experts with extensive managerial and sectoral experience. We are highly competent impact assessment professionals, going beyond existing CSR and sustainability capacities. We are cognizant of the complex nature of ESG. Our experts have the knowledge about financial materiality just as much as the non-financial ESG-related aspects.” Andrew Jamieson continued.

For more information on ESG Enterprise’s new ESG reporting software, visit esgenterprise.com/esg-solution/esg-reporting. For more information on LR Consultant’s ESG services, visit https://lr-consultants.com/esg/.

###

Jen Wang
ESG Enterprise
info@esgenterprise.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Adhesives Market Trends Bring About Adoption Of IoT Technologies In The Manufacturing Process

Adhesives Market Report 2021: COVID-19 Impact And Recovery To 2030

Adhesives Global Market Report 2021: COVID-19 Impact And Recovery To 2030

The Business Research Company’s Adhesives Global Market Report 2021: COVID-19 Impact And Recovery To 2030

LONDON, GREATER LONDON, UK, June 23, 2021 /EINPresswire.com/ — Many adhesive companies are adopting IoT (Internet of Things) technologies to connect equipment and smart devices to obtain real time insights and identify inefficiencies in the manufacturing process. The data obtained is processed, analyzed, and interpreted by plant managers and senior level management to improve quality and achieve optimum production levels. For example, smart systems give information on the working condition and performance of chemical reactors with embedded software and analytics tools to notify plant operators and managers on possible machine breakdowns. Some of the major companies adopting IoT as per adhesives market dynamics include BASF SE, The Dow Chemical Company, and H.B. Fuller.

The adhesives market consists of the sales of adhesives, glues, and caulking compounds by entities (organizations, sole traders or partnerships) that produce adhesives, glues and caulking compounds. The adhesives market is segmented into water-based adhesives, solvent-based adhesives, hot-melt-based adhesives and reactive & other adhesives.

Read More On The Global Adhesives Market Report:
https://www.thebusinessresearchcompany.com/report/adhesives-global-market-report-2020-30-covid-19-impact-and-recovery

The global adhesives market is expected to grow from $58.35 billion in 2020 to $62.44 billion in 2021 at a compound annual growth rate (CAGR) of 7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $75.25 billion in 2025 at a CAGR of 5%.

Asia Pacific is the largest region in the global adhesives market, accounting for 47% of the market in 2020. North America is the second largest region accounting for 24% of the global market. Africa has the smallest adhesives market share.

The major players covered in the global adhesives market are 3M, Henkel, Sika AG, Dow Chemical Co, BASF.

TBRC’s adhesives market report is segmented by type into water-based adhesives, solvent-based adhesives, hot-melt-based adhesives, reactive & other adhesives, by application into packaging, construction, laminates, woodstock and furnishing, automobile, footwear, others, and by product type into acrylic, pva, polyurethanes, styrenic block, epoxy, eva, others.

Adhesives Global Market Report 2021: COVID-19 Impact And Recovery To 2030 is one of a series of new reports from The Business Research Company that provides adhesives global market overview, forecast adhesives global market size and growth for the whole market, adhesives global market segments, and geographies, adhesives global market trends, adhesives market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Adhesives Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2114&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Surgical Sealants And Adhesives Global Market Report 2021: COVID-19 Growth And Change To 2030
(https://www.thebusinessresearchcompany.com/report/surgical-sealants-and-adhesives-market-global-report-2020-30-covid-19-growth-and-change )

Water-Based Adhesives Global Market Report 2021: COVID-19 Impact And Recovery To 2030
(https://www.thebusinessresearchcompany.com/report/water-based-adhesives-global-market-report)

Reactives & Others Adhesives Global Market Report 2020
(https://www.thebusinessresearchcompany.com/report/reactives-and-others-adhesives-global-market-report)

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

What You Need to Know about Recent Discoveries in Cancer Treatment

recent discoveries in cancer treatment

stainless steel casework with stainless steel peg board

Shown above is a blood laboratory with casework and other furniture elements built by Formaspace. It features a long seamless stainless steel countertop that runs the entire length of the laboratory, plus built-in stainless steel drawers and cabinets.

fixed casework in us army lab

Formaspace manufactured custom laboratory furniture for the DoD’s premier Food Analysis and Diagnostic Laboratory (FADL) in San Antonio, Texas, which is one of the largest laboratories of this type in the world.

modular sample processing

Shown above is a mobile workbench in a specimen process laboratory; Formaspace’s heavy-duty steel frame furniture can support sensitive (and expensive) testing equipment safely and securely –for added peace of mind.

Find out about the new discoveries coming from cancer research laboratories, including updated recommendations to help identify cancer in its early stages.

Many ongoing cancer drug trials were also disrupted by the pandemic as patients hesitated to sign up or elected to withdraw out of concerns over the Covid virus.”

— Formaspace

AUSTIN, TEXAS, UNITED STATES, June 22, 2021 /EINPresswire.com/ — In this article, we take a look at the many important recent developments in cancer research.

But first, we should address the effect of the Covid pandemic on cancer research and the Life Sciences sector in general.

As you might expect, Covid has been a disruptive force over the past year, with many cancer research personnel having to adjust to working from home and many labs requiring updates to their facilities, including improving their ventilation systems, installing transparent barriers between lab stations, etc.

Cancer clinicians have also bemoaned the fact that during the height of the pandemic, many patients avoided coming into healthcare facilities at all – a troubling development for those who could have benefited from early cancer detection screening – when clinical treatment is easiest, and outcomes are most promising.

As a result, it’s widely believed we’ll see a significant uptick in cancer detection in the coming months as people return to healthcare facilities for regular screenings.

Many ongoing cancer drug trials were also disrupted by the pandemic as patients hesitated to sign up or elected to withdraw out of concerns over the Covid virus.

On the other hand, there have been some rare positive developments in the Healthcare and Life Sciences industry due to the Covid pandemic:

– One notable development is that the US did not experience any widespread influenza outbreak during the past “flu season,” presumably due to increased personal hygiene, including frequent handwashing as well as widespread mask wearing during the pandemic.

– Thanks to the rapid development and early success of Covid vaccines, there is renewed interest in life science research (including disease research and prevention) by the public, government officials, tech companies, investors, and the media. (We’ll investigate the current rapid growth of the Life Sciences sector in an upcoming series of articles.)

– The FDA and other drug regulators around the world have given provisional (emergency use) approval for RNA-based vaccines from BioNTech and Moderna, validating an approach championed by the once overlooked researcher Kati Kariko. This approval of RNA-based vaccines could greatly speed up the acceptance of other RNA-based therapies that pharma companies have in development, including so-called “cancer vaccines,” which we investigate below.

Could The Success Of Covid Vaccines Point The Way To New Funding Models For Disease Research?

There’s a fourth point as well.

The widely viewed success of “Operation Warp Speed” – the government initiative to provide massive funding to private companies seeking to develop a workable Covid vaccine as fast as possible (while shielding them from potential product liability) – has demonstrated that increased government funding support (and effective management) can deliver results.

This has increased calls to reassess (and hopefully increase) the role of public funding in drug research, with some scientists pointing to the groundbreaking research of Andrew W. Lo and Roger M. Stein, who, along with financial expert John Hull, wrote the 2019 paper “Funding Long Shots” that calls for a completely new funding framework (including Wall Street backing) to provide investor-backed financial support for disease research, including the search for new cures for cancer.

In a world of what many consider highly speculative investments (including SPACs, NFTs, DogeCoins, and the like), one has to believe that increased investment in health research would be a better bet in creating long-term positive change for our society than the alternatives.

The Biden administration has also taken notice of the calls for increased government support and has beefed up funding requests for Life Sciences (including cancer research) in the Recovery Act that passed earlier this year, as well as the proposed Federal Budget and Infrastructure bill.

Hopefully, this new funding will find its way to the likes of the NCI Experimental Therapeutics (NExT) program, which is the National Cancer Institute’s own “mini Operation Warpspeed” that helps coordinate funding for the most promising or novel cancer therapies – from the earliest stages of research all the way through to human clinical trials.

Which Are The Most Common Cancers Today?

Let’s turn our attention now to the latest research in cancer diagnostics, starting with the newest cancer incidence rankings.

At 11.7% of all cancers, breast cancer is now the number one most commonly diagnosed cancer world-wide, having supplanted the incidence of lung cancer (11.4%) – a drop that’s possibly linked to long-running anti-smoking campaigns. The next most common cancer diagnoses on a worldwide basis are colorectal (10%), prostate (7.3%), and stomach cancer (5.6%). In the US, the 2020 rankings are similar, except prostate cancer diagnoses outnumber those of colorectal cancer.

What about long-term trends?

Read more…

Julia Solodovnikova
Formaspace
+1 800-251-1505
email us here


Source: EIN Presswire

Genesee County successfully constructs their limestone unpaved road with Substrata’s Perma-Zyme

Atlas road built with enzyme based soil stabilizer Perma-Zyme

Perma-Zyme treated road in Atlas, MI

A road in Michigan being constructed with enzyme based soil stabilizer Perma-Zyme

The Flushing road being constructed with Perma-Zyme

Another road in Michigan treated with Perma-Zyme

An unpaved road constructed with Perma-Zyme can last up to 15 years with little to no maintenance.

Construction attracted road superintendents from all over the state including Oakland, Huron, and Livingston counties

There was no road dust. It’s amazing. I would definitely recommend the product”

— Shirley Kautman Jones

HENDERSON, NEVADA, UNITED STATES, June 22, 2021 /EINPresswire.com/ — Today Michigan’s Genesee County and biochemical enzyme manufacturer Substrata announced the successful construction of an unpaved road treated with Perma-Zyme in Flushing, MI. The construction of the 1 mile long residential farm road brought in road superintendents from all over Michigan and was able to be completed in just one day.

“Our Carpenter road project went well. It is hardening up well with very little dust. We also had Huron, Livingston, and Oakland county road commissions show up to see the process and learn a little more about the product”, said Genesee County’s Director of Engineering Eric Johnston.

Genesee County had previously been using magnesium chloride to treat the road. Their cost of using magnesium chloride was upwards of $159,000 a year, not including material and labor costs. A standard 1 mile, 2 lane road constructed with Perma-Zyme costs $6,000.

The county had to apply magnesium chloride multiple times throughout the year while Perma-Zyme only has to be applied once and creates a concrete-like surface that lasts up to 15 years with little to no maintenance. Perma-Zyme is also environmentally and worker friendly requiring no special protective equipment while chlorides including magnesium chloride have been shown to be harmful towards the environment.

Flushing’s unpaved road is primarily limestone with clay underneath. Typically Perma-Zyme requires 20 percent clay content for the product to work effectively, however Substrata did extensive testing on Genesee’s soil and determined that Perma-Zyme can work with limestone present. Perma-Zyme has a positive charge and bonds with the negative charge in both clay and limestone which induces an electrochemical reaction that results in a concrete-like surface that gets stronger over time.

Flushing’s road is not the first in Genesee County to use Perma-Zyme. Before 2013 Atlas, Michigan’s Walker road was constantly giving its residents problems when it would tear apart in the spring.

“Walker road has 2 very low spots…the road would get giant frost boils which made the road impassable on several occasions. A lot of the people that lived there would park their car and walk”, said Shirley Kautman Jones, former Vice Chairman of the Genesee County Road Commission.

Shirley took the product to the road commission where they decided to use it on Walker road.

“The people that lived on the road were very excited, after that point it was a huge success. We went over two years without applying calcium chloride to the road. There was no road dust. It’s amazing. I would definitely recommend the product”.

About Substrata

Substrata has quickly become the go-to bio-chemical manufacturer of enzyme-based products, serving government agencies, commercial businesses and farmers worldwide. Products created by Substrata are natural enzyme-based compounds that are ideal for road and soil stabilization, soil conditioning, petroleum bioremediation, cleaning and odor control. To learn more about Substrata products, call 702.825.2500 or visit www.substrata.us.

About Genesee County

Genesee County Government is dedicated to preserving and enhancing the outstanding quality of life which has made our community a desirable place to live, work, and raise our children. Through the provisions of cost effective, superior services, Genesee County Government will ensure the promotion of orderly growth for the economic health and safety of its citizens.

Alfonso Martinez
Substrata
+1 702-825-5200
amartinez@substrata.us
Visit us on social media:
Facebook
LinkedIn


Source: EIN Presswire

MIP Diagnostics’ COVID-19 nanoMIP offers significantly improved sensitivity to antibodies in a diagnostic sensor

MIP Diagnostics logo - Blue circle with white and yellow molecule cut out

MIP Diagnostics' COVID-19 nanoMIP outperforms commercial antibodies in a sensor platform, which could enable improved detection of lower viral loads.

BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, June 22, 2021 /EINPresswire.com/ — MIP Diagnostics Ltd. has today shared the news that its COVID-19 nanoMIP outperforms commercial antibodies in a sensor platform, which could enable improved detection of lower viral loads during a wider infection period.

Following the launch of its COVID-19 nanoMIP in April 2021, the business has worked with external collaborators to assess the performance of the nanoMIP compared to antibodies, which are used in the majority of rapid diagnostic devices. nanoMIPs are animal free, synthetic alternatives that are chemically produced to mimic an antibody. They can be developed much more rapidly, and offer more consistent, robust properties, making them ideal for use in diagnostic tests with high demand such as those for COVID-19.

The side-by-side analysis compared the sensitivity performance of the MIP Diagnostics’ COVID-19 nanoMIP against a flagship antibody from a leading commercial supplier in a thermal resistance sensor platform. The sensor electrode with nanoMIPs immobilized demonstrated a limit of detection of <5fg/ml, 20 times lower than that of the electrode with the antibodies immobilized which showed 105fg/ml detection limit.

Alan Thomson, Chief Scientific Officer at MIP Diagnostics said, “Antibodies have a long history of use within the IVD sector, and the industry has quickly become accustomed to working around their limitations with regards to stability and lot to lot consistency. nanoMIPs can easily overcome these challenges, and this new data demonstrates they can also offer not just comparable, but superior sensitivity performance when compared side-by-side with antibodies in a sensor application. As this level of performance is demonstrated across more sensor devices, we envisage nanoMIPs becoming the preferred detection agent for sensor developers as well as other diagnostic methods in the future.”

Further tests on other sensor platforms are currently underway and MIP Diagnostics is actively expanding is portfolio of nanoMIPs to other diagnostic biomarkers and active compounds. The COVID-19 nanoMIP is now available for sampling to diagnostic sensor developers.

Keli Stockbridge
MIP Diagnostics
+44 1234589725
keli.stockbridge@mip-dx.com
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire